Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17300568 | 0.95 | LMNA (0.33) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL15909701 | 0.91 | MGLL (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL15909700 | 0.86 | MGLL (0.41) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL8524177 | 0.76 | PIK3CD (0.45) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL14865023 | 0.74 | MGLL (0.44) | MGLL | |
| SCHEMBL8544980 | 0.71 | PIK3CD (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL17300564 | 0.70 | THRB (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL17300566 | 0.70 | THRB (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL15909714 | 0.70 | LMNA (0.37) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL17300567 | 0.70 | LMNA (0.37) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9751866-B2 | Hemi-aminal ethers and thioethers of N-alkenyl cyclic compounds | ISP INVESTMENTS LLC (US) | 2017-09-05 | — | — | US | disclosed |
| US-20150344461-A1 | HEMI-AMINAL ETHERS AND THIOETHERS OF N-ALKENYL CYCLIC COMPOUNDS | ISP INVESTMENTS INC. (US) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344461-A1 | HEMI-AMINAL ETHERS AND THIOETHERS OF N-ALKENYL CYCLIC COMPOUNDS | TST, AHR, ALOX12 | CHRM2 1169/4885CHRM4 1418/4885CHRM5 2638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.